Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: Disease-free survival as a surrogate endpoint for overall survival in adjuvant trials of pancreatic cancer: a meta-analysis of 20 randomized controlled trials

Fig. 4

Leave-one-out cross-validation analysis of the prediction of OS by treatment effect on DFS: observed HR for OS for left-out trial vs. predicted HR for OS and 95% prediction interval for predicted HR for OS. To assess model accuracy, a leave-one-out cross-validation strategy was used: each unit of analysis was left out once, and the linear model was then constructed from scratch using the remaining data [33]. This model was then re-applied to the left-out study in order to compare the predicted and observed treatment effect on OS. Based on the linear regression models, a 95% prediction interval was calculated compare the predicted and observed treatment effect on OS. OS, overall survival; DFS, disease-free survival; HR, hazard ratio

Back to article page